Drug Disposition II Flashcards

1
Q

Drug metabolism results in: (3)

A

elimination/renal clearance

blood levels

effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • A member of the cytochrome P450 (CYP) enzyme superfamily
  • High levels in the liver
  • Metabolizes many drugs
  • Genetic polymorphims results in humans with
    • “normal” enzyme activity
    • very low activity (no effect of codeine)
    • very high activity
A

CYP 2D6

which is a gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Key information needed to predict drug metabolism in your patient (3)

A
  • what enzymes metabolize
  • genetic factors that affect enzyme
  • drug activated or inactivated by metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are consequences of biotransformation? (2)

A
  • Increased polarity (water solubility), which results in facilitated excretion
  • Pharmacological or toxicological result
    • Inactivation (usually)
    • Activation (sometimes)
    • No effect
    • Metabolite and parent drug may both be active
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sites of drug biotransformation (5):

A
  • Liver
  • GI
  • Kidney
  • Respiratory tissues: lung, nose
  • Brain, skin, heart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Common phases of drug metabolism: (2)

Note: don’t necessarily have to go through both phases.

A
  • non-conjugative, (non-synthetic )
    • Oxidations
    • Reductions, Hydrolyses

Note: Adds or unmasks functional group
Usually inactivates, sometimes activates

  • conjugative (synthetic)
  • Conjugations (covalent coupling of drug to endogenous molecule)
    • Increases polarity
    • Adds bulky moiety
    • Usually inactivating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is this?

  • “microsomal” endoplasmic reticulum mixed-function oxidase
  • uses NADPH and O2 to metabolize drugs
A

Cytochrome P450s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The major human cytochrome P450s involved in clinical drug metabolism: (4)

A

CYP 3 A 4

2 D 6

1 A 2

2 C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Conjugation (Phase II) reactions pathway involves: (2)

A
  • Need high-energy cosubstrate
    • Activities reduced when low ATP
  • Adds polar or ionizable group, increasing water solubility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In phase II reactions, what is the most common conjugation reaction?

  • Has many enzymes and conjugates to many functional groups
  • Are often excreted in the bile
A

glucuronides

during glucuronidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

KNOW:

Other conjugation reactions: (4)

GASM

A

Acetylation
Sulfation
Methylation
Glutathione conjugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which conjugation reaction’s main purpose is:

  • to protect cells from reactive drugs and metabolites
  • is not usually a major pathway for drug elimination from the plasma
A

glutathione conjugation

responsible for actetominophen poisoning for example

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Factors affecting drug metabolism: (2)

A
  • Increased therapeutic/ toxic effect due to reduced metabolism
    • neonates, liver disease, genetics, diet, herbal preparations
  • Decreased therapeutic effect due to increased metabolism
    • Gene amplification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

P450 modifiers in natural products: (2)

A

grapefruit juice

St. John’s Wort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In pharmacogenetics, genes can respond to drugs: (2)

A

monomorphic

polymorphic (increased plasma concentration/magnitude of response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pharmacodynamic polymorphisms in drugs results in alterations in ______ molecules.

A

target

17
Q

This polymorphism;

  • usually involves alterations in drug metabolizing enzymes
  • more prevalent due to lower selection pressure
A

pharmacokinetic

18
Q

Detection of pharmacogenetic traits: (2)

A
  • Phenotyping

Ex. Pharmacokinetics
Urinary metabolite ratios
Enzyme activities in peripheral blood
Can detect all mutant alleles
Affected genetic factors, can change with time

  • Genotyping

Easily done by sequencing or e.g. gene array chips
Does not always reflect phenotype
Only detects known mutant alleles

19
Q

Key themes/concepts in pharmacogenetics (2)

A
  • Multiple defective alleles/haplotypes
  • Allele distribution can vary substantially in different racial/ethnic groups
20
Q

CYP2D6 polymorphism involves increased response to the following drug classes:

A
  • cardiovascular
  • beta blockers
  • tricyclic antidepressents
21
Q
  • 10% of Caucasians
  • 1% of Orientals
  • Large number of mutant (defective) alleles
A

CYP2D6 polymorphism

22
Q

Pharmacodynamic polymorphisms in non-target genes is:

A

Malignant Hyperthermia